4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000904454-20-000398
Options or other derivatives
- Director acquired 31,279 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| TREU JESSE I Director | 2020-06-09 | Grant or award · Stock Option (right to buy) | +26,503 | 26,503 | D: show line 1 in the form | |||||
| TREU JESSE I Director | 2020-06-09 | Grant or award · Stock Option (right to buy) | +2,465 | 2,465 | D: show line 2 in the form | |||||
| TREU JESSE I Director | 2020-06-09 | Grant or award · Stock Option (right to buy) | +2,311 | 2,311 | D: show line 3 in the form |
Loading xslF345X03/edgar.xml…